ABSTRACT
[...]8 studies were included. Glucocorticoids, Azithromycin, Remdesivir, Ropinavir/ritonavir combination therapy, Chloroquine (CQ), Hydroxychloroquine (HCQ), Interferon beta, IL-6 inhibitor (Tocilizumab), and Favipiravir are some of the drugs being recently used for patients with COVID-19. Results To evaluate the clinical efficacy of CQ and HCQ on the treatment of COVID-19-induced pneumonia and their effect on mortality and disease progression in this group of patients, eight studies (including five systematic reviews and three systematic reviews with meta-analysis) were included. [...]its clinical use must either adhere to the Monitored Emergency Use of Unregistered and Investigational Interventions (MEURI) framework or be ethically approved by the World Health Organization as a validated test. 2- Patil et at.2 announced the results of 100 studies, including 590368 cases, as follows: HCQ and CQ are effective in several studies (in vitro and clinical studies) in the treatment of mild to severe pneumonia